PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2022.22%
Net income growth above 1.5x CRK's 225.01%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-7.74%
Both reduce yoy D&A, with CRK at -10.01%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-300.00%
Negative yoy deferred tax while CRK stands at 398.05%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
173.91%
Well above CRK's 58.33% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-131.37%
AR is negative yoy while CRK is 57.03%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
606.19%
AP growth well above CRK's 89.82%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
173.91%
Some yoy usage while CRK is negative at -56.19%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-84.21%
Both negative yoy, with CRK at -16621.86%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-8.87%
Negative yoy CFO while CRK is 3.21%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-15.34%
Both yoy lines negative, with CRK at -7.02%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
87.44%
Less M&A spending yoy vs. CRK's 276166.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
166.67%
Less 'other investing' outflow yoy vs. CRK's 276166.00%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-10.35%
We reduce yoy invests while CRK stands at 74.57%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
99.81%
We repay more while CRK is negative at -224.14%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.